Amyloid β protein

Amyloid β protein(β淀粉样蛋白)

Amyloid beta ( or Abeta) denotes peptides of 36–43 amino acids that are the main component of the amyloid plaques found in the brains of people with Alzheimer's disease. The peptides derive from the amyloid precursor protein (APP), which is cleaved by beta secretase and gamma secretase to yield Aβ. Aβ molecules can aggregate to form flexible soluble oligomers which may exist in several forms. It is now believed that certain misfolded oligomers (known as "seeds") can induce other Aβ molecules to also take the misfolded oligomeric form, leading to a chain reaction akin to a prion infection. The oligomers are toxic to nerve cells. The other protein implicated in Alzheimer's disease, tau protein, also forms such prion-like misfolded oligomers, and there is some evidence that misfolded Aβ can induce tau to misfold.

The normal function of Aβ is not well understood. Though some animal studies have shown that the absence of Aβ does not lead to any obvious loss of physiological function, several potential activities have been discovered for Aβ, including activation of kinase enzymes, protection against oxidative stress, regulation of cholesterol transport, functioning as a transcription factor, and anti-microbial activity (potentially associated with Aβ's pro-inflammatory activity).

The glymphatic system clears metabolic waste from the mammalian brain, and in particular amyloid beta. Indeed, a number of proteases have been implicated by both genetic and biochemical studies as being responsible for the recognition and degradation of amyloid beta; these include insulin degrading enzyme.and presequence protease. The rate of removal is significantly increased during sleep. However, the significance of the lymphatic system in Aβ clearance in Alzheimer's disease is unknown.

Amyloid β protein 相关产品(164)

  • GA20525 structure
    GA20525Acetyl-(N-Me-Leu¹⁷,N-Me-Phe¹⁹)-Amyloid β-Protein (16-20) amide
    CAS: 461640-33-5

    Membrane-permeable inhibitor of Aβ (1-40) fibrillogenesis.

  • GA20526 structure
    GA20526Acetyl-(Pro¹⁸,Asp²¹)-Amyloid β-Protein (17-21) amide
    CAS: 339990-02-2

    五肽 Ac-LPFFD-NH? (iAβ5p) 是产品 H-4876 的类似物,具有少量化学修饰,可增强其抗蛋白水解降解的稳定性。 iAβ5p 充当 77777#946;-片断肽并以比已知被大脑选择性吸收的大多数蛋白质和肽更高的速率穿过血脑屏障,因此假设该肽被特异性运输到大脑。 iAβ5p 还报道了两种不同的转基因阿尔茨海默病 (AD) 模型中与淀粉样斑块减少相关的神经元存活显着增加和脑部炎症减少。

  • GA20533 structure
    GA20533Acetyl-Amyloid β/A4 Protein Precursor₇₇₀ (96-110) (cyclized)
    CAS: 289634-54-4

    This cyclized peptide which is homologous to the heparin-binding domain of APP, binds strongly to heparin and inhibits binding of ¹²?I-labeled APP to heparin (IC??= 10??M). The peptide blocks the heparan sulfate proteoglycan-dependent stimulatory effect of APP on neurite outgrowth.

  • GA20534 structure
    GA20534Acetyl-Amyloid β-Protein (15-20) amide
    CAS: 189064-06-0

    Incubation of Ac-QKLVFF-NH? with the amyloid β-protein (1-40) inhibited polymerization of the amyloid β-protein (1-40) into amyloid fibrils. The peptide is thought to block the polymerization sites.

  • GA20535 structure
    GA20535Acetyl-Amyloid β-Protein (1-6) amide
    CAS: 903883-22-7

    Experiments using sub-peptides of Aβ42 revealed that the epitope identified by the antibody A8, as described by Ying and coworkers, lies within the 1-6 region of Aβ. The antibody displays high affinity for soluble Aβ42 oligomers in the molecular weight range of 16.5-25 kDa, and detected target antigen in brain sections from senescence-accelerated SAMP 8 mice. Amidated or acetylated and amidated forms of the sequence were used for example for quantitative structure retention relationships (QSRR) experiments. The latter could allow prediction of reversed-phase high-performance liquid chromatography (HPLC) retention of peptides, as reported by Kaliszan and coworkers.

  • GA20718 structure
    GA20718Amyloid β/A4 Protein Precursor₇₇₀ (667-676)
    CAS: 252256-37-4

    The peptide substrate APP (667-676), SEVKMDAEFR, corresponds to the wild-type amyloid precursor protein (APP) β-secretase cleavage site. SEVKMDAEFR has been used for assaying β-secretase activity.

  • GA20719 structure
    GA20719Amyloid β/A4 Protein Precursor₇₇₀ (740-770)
    CAS: 1802086-24-3

    Amyloid β/A4 Protein Precursor??? (740-770) corresponds to a C-terminal amyloid precursor protein (APP) fragment known as C31. This fragment is intracellularly generated by proteolytic cleavage of APP by caspases-8 and -9. C31 had a proapoptotic and a cytotoxic effect on neuronal cells and was shown to be present in brains of Alzheimer's disease (AD) patients. In cultured cells caspase cleavage of APP was induced by amyloid β-protein and the subsequent generation of C31 contributed to the apoptotic cell death associated with amyloid β-protein. Amyloid precursor binding protein BP1 (APP-BP1) a cell cycle protein which is increased in AD brain was demonstrated to bind to the C31 region of APP and to mediate APP-induced apoptosis.

  • GA20720 structure
    GA20720Amyloid β-Protein (10-35)
    CAS: 237753-66-1

    Amyloid β-protein (10-35), YEVHHQKLVFFAEDVGSNKGAIIGLM, was used as a truncated peptide model for the full-length amyloid β-proteins (1-40) and (1-42) in high-resolution structural studies. In contrast to the full-length amyloid β-proteins, amyloid β-protein (10-35) allowed the controlled and reproducible formation of homogeneous fibrils from aqueous solutions of defined pH, ionic strength and soluble peptide concentration necessary for high-resolution structural studies.

  • GA20721 structure
  • GA20722 structure
    GA20722Amyloid β-Protein (1-14)
    CAS: 186319-74-4

    The N-terminal Aβ fragments Aβ1-14, Aβ1-15 (H-6368), and Aβ1-16 (H-2958) are elevated in cell media and in CSF in response to γ-secretase inhibitor treatment. The presence of these small peptides is consistent with a catabolic amyloid precursor protein cleavage pathway by β- followed by α-secretase. It has been shown that Aβ1-14, Aβ1-15, and Aβ1-16 increase dose-dependently in response to γ-secretase inhibitor treatment while Aβ1-42 levels are unchanged.

  • GA20723 structure
  • GA20724 structure
  • GA20725 structure
    GA20725Amyloid β-Protein (1-37)
    CAS: 186359-67-1

    淀粉样蛋白 β-蛋白质 (1-37) 与阿尔茨海默病的简易精神状态检查 (MMSE) 评分中度相关。

  • GA20726 structure
    GA20726Amyloid β-Protein (1-38)
    CAS: 131438-74-9

    Like Aβ (25-35) (H-1192), the Aβ fragment (1-38) destabilizes calcium homeostasis and renders human cortical neurones vulnerable to environmental insults.

  • GA20727 structure
    GA20727Amyloid β-Protein (1-39)
    CAS: 115427-62-8

    Small quantities of Aβ37, 38 and 39 can be detected in CSF together with Aβ40, the most abundant Aβ homolog, Aβ42, and N-terminally truncated amyloid peptides. The relative amounts depend on the variant of Alzheimer's disease. The C-terminally truncated amyloid peptides are also found in amyloid plaques.

  • GA20728 structure
  • GA20729 structure
  • GA20731 structure
  • GA20733 structure
    GA20733Amyloid β-Protein (1-42)
    CAS: 107761-42-2
    纯度: >98.00%

    与内盐相比,Aβ42 的盐酸盐在 pH 7.4 时更容易聚集。

  • GA20736 structure
    GA20736Amyloid β-Protein (1-43)
    CAS: 134500-80-4

    淀粉样蛋白 β-Protein (1-43) 比久负盛名的 Aβ1-42 更容易聚集并具有更高的毒性。

  • GA20737 structure
    GA20737Amyloid β-Protein (1-46)
    CAS: 285554-31-6

    Precursor of the secreted amyloid β-protein (1-40) and (1-42). The identification of amyloid-β-protein (1-46) led to the identification of a zeta-cleavage site between the known γ- and ε-cleavage sites within the transmembrane domain of amyloid-β precursor protein (APP).

  • GA20738 structure
    GA20738Amyloid β-Protein (1-6)
    CAS: 214550-64-8

    Experiments using sub-peptides of Aβ42 revealed that the epitope identified by the antibody A8, as described by Ying and coworkers, lies within the 1-6 region of Aβ. The antibody displays high affinity for soluble Aβ42 oligomers in the molecular weight range of 16.5-25 kDa, and detected target antigen in brain sections from senescence-accelerated SAMP 8 mice.

  • GA20739 structure
    GA20739Amyloid β-Protein (1-6) amide
    CAS: 1361235-89-3

    Experiments using sub-peptides of Aβ42 revealed that the epitope identified by the antibody A8, as described by Ying and coworkers, lies within the 1-6 region of Aβ. The antibody displays high affinity for soluble Aβ42 oligomers in the molecular weight range of 16.5-25 kDa, and detected target antigen in brain sections from senescence-accelerated SAMP 8 mice. Amidated or acetylated and amidated forms of the sequence were used for example for quantitative structure retention relationships (QSRR) experiments. The latter could allow prediction of reversed-phase high-performance liquid chromatography (HPLC) retention of peptides, as reported by Kaliszan and coworkers.

  • GA20740 structure
    GA20740Amyloid β-Protein (16-20)
    CAS: 153247-40-6

    Amyloid β-Protein (16-20)是一种β-淀粉样蛋白的五个氨基酸片段。